Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 4.51B |
| Enterprise Value | 2.37B |
| P/E Ratio | -5.34 |
| PEG Ratio | 0.17 |
| Price/Sales Ratio | 3.65 |
| Price/Book Ratio | 0.61 |
| Enterprise/Revenue | 1.84 |
| Enterprise/EBITDA | -3.26 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.65 |
| Operating Margin | -0.59 |
| Return On Assets | -0.1 |
| Return On Equity | -0.11 |
| Revenue | 947.38M |
| Revenue/Share | 5.25 |
| Gross Profit | 958.99M |
| EBITDA | -357.78M |
| Net Income | -573.6M |
| Diluted EPS | -2.93 |
| Total Cash | 2.27B |
| Total Cash/Share | 11.85 |
| Total Debt | 355.56M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 3.42 |
| Book Value Per Share | 30.09 |
| 52-Week Change | -33.15 |
| 52-Week High | 28.99 |
| 52-Week Low | 16.8 |
| Moving Average 50 Days | 18.53 |
| Moving Average 200 Days | 20.75 |
| Average Volume | 1.77M |
| Shares Outstanding | 201.6M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.01 |
| Last Split Factor | 6:5 |
| Last Split Date | June 26, 2023 |